AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Mesa Laboratories Inc
XNAS · usd
SIC 3823 · INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
FIGI BBG001S5T762
128.66▼ 0.44 (-0.34%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
129.10
Day's Range
124.95 – 129.63
52-Week Range
69.51 – 144.35
Volume
88.2K
Avg Volume
106.0K
Share Statistics
Shares Outstanding
Employees
730
Exchange
XNAS
Listed
1984-02-29
Share count as of August 3, 2026

Mesa Laboratories Inc (MLAB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Mesa Laboratories Inc (MLAB)
What is Mesa Laboratories Inc's Market Cap?
Mesa Laboratories Inc's Market Cap is $720.0M, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's Enterprise Value?
Mesa Laboratories Inc's Enterprise Value is $755.4M, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's Trailing P/E?
Mesa Laboratories Inc's Trailing P/E is 150.0×, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's Price / Sales?
Mesa Laboratories Inc's Price / Sales is 2.9×, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's EV / Revenue?
Mesa Laboratories Inc's EV / Revenue is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's EV / EBITDA?
Mesa Laboratories Inc's EV / EBITDA is 16.7×, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's Revenue (TTM)?
Mesa Laboratories Inc's Revenue (TTM) is $249.7M, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's Net Income (TTM)?
Mesa Laboratories Inc's Net Income (TTM) is $4.8M, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's EBITDA?
Mesa Laboratories Inc's EBITDA is $45.4M, based on as-reported figures from SEC (XBRL) filings.
What is Mesa Laboratories Inc's Diluted EPS (TTM)?
Mesa Laboratories Inc's Diluted EPS (TTM) is 0.86, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · MLABAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+1.0%+2.6%+3.6%+5.0%
Cost of revenue
Gross profit
% of revenue64.9%66.2%64.2%61.5%
Operating expense:
Selling
General and administrative
Research and development
Total operating expense
% of revenue53.2%61.9%51.9%53.7%
Operating income
% of revenue11.7%4.3%12.2%7.8%
Non-operating expense (income):
Interest expense and amortization of debt issuance costs
Other expense (income), net
Total non-operating expense (income), net
Earnings before income taxes
Income tax expense
Net income
% of revenue4.7%-6.5%5.6%4.1%
Basic (in dollars per share)
Diluted (in dollars per share)